Personalized Nutrition and Drug–Nutrient Interactions

  • Yousef I. Hassan


Nutrition is the cornerstone of health. This chapter explores the relationship between dietary factors and the development of modern concepts in controlling and preventing chronic health issues such as tumors, diabetes, and obesity. While recent advances in molecular biology enhanced our understanding of the root causes of such diseases, future implementation of personalized-nutrition and medicine could generate dietary recommendations and interventions that will achieve optimum health standards and provide maximum disease prevention and control.

The conventional pharmacokinetics approach completely ignores environmental (such as intestinal microbial flora) or lifestyle factors (such as dietary choices) that influence many physiological parameters. These factors in fact are essential in dictating the bioavailability, metabolism, and degradation, hence the efficacy of most of the modern drugs. The alternative approach offered by modern nutrigenomics and pharmacogenomics, accounts for such variables in order to intervene in more predictable fashion with better prognosis outcomes.


Neural Tube Defect Folate Supplementation Odorant Receptor Dietary Choice Personalized Nutrition 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. Aagaard-Tillery KM, Grove K et al (2008) Developmental origins of disease and determinants of chromatin structure: maternal diet modifies the primate fetal epigenome. J Mol Endocrinol 41(2):91–102PubMedCentralPubMedCrossRefGoogle Scholar
  2. Alasfoor D, Elsayed MK et al (2010) Spina bifida and birth outcome before and after fortification of flour with iron and folic acid in Oman. East Mediterr Health J 16(5):533–538PubMedGoogle Scholar
  3. Allfrey V, Faulkner RM et al (1964) Acetylation and methylation of histones and their possible role in the regulation of RNA synthesis. Proc Natl Acad Sci USA 51:786–794PubMedCentralPubMedCrossRefGoogle Scholar
  4. Almal SH, Padh H (2012) Implications of gene copy-number variation in health and diseases. J Hum Genet 57(1):6–13PubMedCrossRefGoogle Scholar
  5. Almasy L (2012) The role of phenotype in gene discovery in the whole genome sequencing era. Hum Genet 131(10):1533–1540PubMedCentralPubMedCrossRefGoogle Scholar
  6. Almeida LC, Cardoso MA (2010) Recommendations for folate intake in women: implications for public health strategies. Cad Saude Publica 26(11):2011–2026PubMedCrossRefGoogle Scholar
  7. Amarin ZO, Obeidat AZ (2010) Effect of folic acid fortification on the incidence of neural tube defects. Paediatr Perinat Epidemiol 24(4):349–351PubMedCrossRefGoogle Scholar
  8. Andersen V, Christensen J et al (2011) Polymorphisms in NF-kappaB, PXR, LXR, PPARgamma and risk of inflammatory bowel disease. World J Gastroenterol 17(2):197–206PubMedCentralPubMedCrossRefGoogle Scholar
  9. Antequera F, Bird A (1993) Number of CpG islands and genes in human and mouse. Proc Natl Acad Sci USA 90(24):11995–11999PubMedCentralPubMedCrossRefGoogle Scholar
  10. Arai E, Kanai Y (2010) Genetic and epigenetic alterations during renal carcinogenesis. Int J Clin Exp Pathol 4(1):58–73PubMedCentralPubMedGoogle Scholar
  11. Arregui M, Fisher E et al (2012) Significant associations of the rs2943634 (2q36.3) genetic polymorphism with adiponectin, high density lipoprotein cholesterol and ischemic stroke. Gene 494(2):190–195PubMedCrossRefGoogle Scholar
  12. Bartal A, Matrai Z et al (2012) Novel oral anticancer drugs: a review of adverse drug reactions, interactions and patient adherence. Orv Hetil 153(2):66–78PubMedCrossRefGoogle Scholar
  13. Beard CM, Panser LA et al (2011) Is excess folic acid supplementation a risk factor for autism? Med Hypotheses 77(1):15–17PubMedCrossRefGoogle Scholar
  14. Bharathy N, Taneja R (2012) Methylation muscles into transcription factor silencing. Transcription 3(5):215–220Google Scholar
  15. Bian L, Yang JD et al (2004) Insulin-degrading enzyme and Alzheimer disease: a genetic association study in the Han Chinese. Neurology 63(2):241–245PubMedCrossRefGoogle Scholar
  16. Bird AP (1986) CpG-rich islands and the function of DNA methylation. Nature 321(6067):209–213PubMedCrossRefGoogle Scholar
  17. Bird A (2007) Perceptions of epigenetics. Nature 447(7143):396–398PubMedCrossRefGoogle Scholar
  18. Bodzioch M, Orso E et al (1999) The gene encoding ATP-binding cassette transporter 1 is mutated in Tangier disease. Nat Genet 22(4):347–351PubMedCrossRefGoogle Scholar
  19. Bottomley MJ (2004) Structures of protein domains that create or recognize histone modifications. EMBO Rep 5(5):464–469PubMedCentralPubMedCrossRefGoogle Scholar
  20. Boullata JI, Hudson LM (2012) Drug-nutrient interactions: a broad view with implications for practice. J Acad Nutr Diet 112(4):506–517PubMedCrossRefGoogle Scholar
  21. Boutant M, Ramos OH et al (2012) Glucose-dependent regulation of NR2F2 promoter and influence of SNP-rs3743462 on whole body insulin sensitivity. PLoS One 7(5):e35810PubMedCentralPubMedCrossRefGoogle Scholar
  22. Boyles AL, Wilcox AJ et al (2008) Folate and one-carbon metabolism gene polymorphisms and their associations with oral facial clefts. Am J Med Genet A146A(4):440–449CrossRefGoogle Scholar
  23. Bremner EA, Mainland JD et al (2003) The prevalence of androstenone anosmia. Chem Senses 28(5):423–432PubMedCrossRefGoogle Scholar
  24. Bustin M, Rall SC et al (1969) Histone structure: asymmetric distribution of lysine residues in lysine-rich histone. Science 163:391–393PubMedCrossRefGoogle Scholar
  25. Carlsohn A, Cassel M et al (2011) How much is too much? A case report of nutritional supplement use of a high-performance athlete. Br J Nutr 105:1724–1728Google Scholar
  26. Caudill MA, Cruz AC et al (1997) Folate status response to controlled folate intake in pregnant women. J Nutr 127(12):2363–2370PubMedGoogle Scholar
  27. Chan D, Cushnie DW et al (2010) Strain-specific defects in testicular development and sperm epigenetic patterns in 5,10-methylenetetrahydrofolate reductase-deficient mice. Endocrinology 151(7):3363–3373PubMedCrossRefGoogle Scholar
  28. Chen P, Liang J et al (2008) Association of common PALB2 polymorphisms with breast cancer risk: a case-control study. Clin Cancer Res 14(18):5931–5937PubMedCrossRefGoogle Scholar
  29. Chen QY, Alarcon S et al (2009) Perceptual variation in umami taste and polymorphisms in TAS1R taste receptor genes. Am J Clin Nutr 90(3):770S–779SPubMedCentralPubMedCrossRefGoogle Scholar
  30. Cheung P, Allis CD et al (2000) Signaling to chromatin through histone modifications. Cell 103:263–271PubMedCrossRefGoogle Scholar
  31. Cui XY, He GZ (2005) Single nucleotide polymorphisms, inflammation and nutrition of genes. Zhongguo Yi Xue Ke Xue Yuan Xue Bao 27(6):790–792PubMedGoogle Scholar
  32. Donley G, Hull SC et al (2012) Prenatal whole genome sequencing: just because we can, should we? Hastings Cent Rep 42(4):28–40PubMedGoogle Scholar
  33. Duell EJ, Sala N et al (2012) Genetic variation in alcohol dehydrogenase (ADH1A, ADH1B, ADH1C, ADH7) and aldehyde dehydrogenase (ALDH2), alcohol consumption and gastric cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort. Carcinogenesis 33(2):361–367PubMedCrossRefGoogle Scholar
  34. Ea CK, Hao S et al (2012) EHMT1 binds to NF-κB p50 and represses gene expression. J Biol Chem 287(37):31207–31217PubMedCentralPubMedCrossRefGoogle Scholar
  35. Engler MB (2009) Nutrigenomics in cardiovascular disease: implications for the future. Prog Cardiovasc Nurs 24(4):190–195PubMedCrossRefGoogle Scholar
  36. Ericson UC, Ivarsson MI et al (2009) Increased breast cancer risk at high plasma folate concentrations among women with the MTHFR 677T allele. Am J Clin Nutr 90(5):1380–1389PubMedCrossRefGoogle Scholar
  37. Fay LB, German JB (2008) Personalizing foods: is genotype necessary? Curr Opin Biotechnol 19(2):121–128PubMedCrossRefGoogle Scholar
  38. Finnell RH, Shaw GM et al (2008) Gene-nutrient interactions: importance of folic acid and vitamin B12 during early embryogenesis. Food Nutr Bull 29(2 Suppl):S86–S98; discussion S99–100PubMedGoogle Scholar
  39. Fischer R, Griffin F et al (1961) Taste thresholds and food dislikes. Nature 191:1328PubMedCrossRefGoogle Scholar
  40. Fischer R, Griffin F et al (1963) Taste thresholds, cigarette smoking, and food dislikes. Med Exp Int J Exp Med 9:151–167PubMedGoogle Scholar
  41. Fisher E, Schreiber S et al (2011) A two-step association study identifies CAV2 rs2270188 single nucleotide polymorphism interaction with fat intake in type 2 diabetes risk. J Nutr 141(2):177–181PubMedCrossRefGoogle Scholar
  42. Frayling TM, Timpson NJ et al (2007) A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity. Science 316(5826):889–894PubMedCentralPubMedCrossRefGoogle Scholar
  43. Ganesh V, Hettiarachchy NS (2012) Nutriproteomics: a promising tool to link diet and diseases in nutritional research. Biochim Biophys Acta 1824(10):1107–1117PubMedCrossRefGoogle Scholar
  44. Gonzalez Sanchez JL, Serrano Rios M et al (2002) Effect of the Pro12Ala polymorphism of the peroxisome proliferator-activated receptor gamma-2 gene on adiposity, insulin sensitivity and lipid profile in the Spanish population. Eur J Endocrinol 147(4):495–501PubMedCrossRefGoogle Scholar
  45. Hasin-Brumshtein Y, Lancet D et al (2009) Human olfaction: from genomic variation to phenotypic diversity. Trends Genet 25(4):178–184PubMedCrossRefGoogle Scholar
  46. Hassan YI, Zempleni J (2010) Molecular aspects of physical performance and nutritional assessment. In: Driskell JA, Wolinksy I (eds) Nutritional assessment of athletes, 2nd edn. Taylor and Francis, Inc, Boca Raton, pp 212–232Google Scholar
  47. Hayes JE, Wallace MR et al (2011) Allelic variation in TAS2R bitter receptor genes associates with variation in sensations from and ingestive behaviors toward common bitter beverages in adults. Chem Senses 36(3):311–319PubMedCentralPubMedCrossRefGoogle Scholar
  48. Hinde K, German JB (2012) Food in an evolutionary context: insights from mother’s milk. J Sci Food Agric 92(11):2219–2223PubMedCrossRefGoogle Scholar
  49. Hines LE, Murphy JE (2011) Potentially harmful drug-drug interactions in the elderly: a review. Am J Geriatr Pharmacother 9(6):364–377PubMedCrossRefGoogle Scholar
  50. Ho E, Zempleni J (2009) Overview to symposium “Nutrients and epigenetic regulation of gene expression”. J Nutr 139(12):2387–2388PubMedCrossRefGoogle Scholar
  51. Johnson AR, Lao S et al (2012) Choline dehydrogenase polymorphism rs12676 is a functional variation and is associated with changes in human sperm cell function. PLoS One 7(4):e36047PubMedCentralPubMedCrossRefGoogle Scholar
  52. Kaput J (2008) Nutrigenomics research for personalized nutrition and medicine. Curr Opin Biotechnol 19(2):110–120PubMedCrossRefGoogle Scholar
  53. Keller A, Zhuang H et al (2007) Genetic variation in a human odorant receptor alters odour perception. Nature 449(7161):468–472PubMedCrossRefGoogle Scholar
  54. Khabour OF, Wehaibi SH et al (2012) Association of adiponectin with hypertension in type 2 diabetic patients: the gender effect. Clin Exp Hypertens: 1–6Google Scholar
  55. Kim U, Wooding S et al (2005) Worldwide haplotype diversity and coding sequence variation at human bitter taste receptor loci. Hum Mutat 26(3):199–204PubMedCrossRefGoogle Scholar
  56. Knouff C, Auwerx J (2004) Peroxisome proliferator-activated receptor-gamma calls for activation in moderation: lessons from genetics and pharmacology. Endocr Rev 25(6):899–918PubMedCrossRefGoogle Scholar
  57. Lin KW, Birmingham E (2010) Folic acid for the prevention of neural tube defects. Am Fam Physician 82(12):1533PubMedGoogle Scholar
  58. Lovegrove JA, Gitau R (2008) Nutrigenetics and CVD: what does the future hold? Proc Nutr Soc 67(2):206–213PubMedCrossRefGoogle Scholar
  59. Lucock MD (2006) Synergy of genes and nutrients: the case of homocysteine. Curr Opin Clin Nutr Metab Care 9(6):748–756PubMedCrossRefGoogle Scholar
  60. Major JM, Yu K et al (2012) Genome-wide association study identifies three common variants associated with serologic response to vitamin E supplementation in men. J Nutr 142(5):866–871PubMedCentralPubMedCrossRefGoogle Scholar
  61. McDonald RB, Ruhe RC (2011) Aging and longevity: why knowing the difference is important to nutrition research. Nutrients 3(3):274–282PubMedCentralPubMedCrossRefGoogle Scholar
  62. McRae JF, Mainland JD et al (2012) Genetic variation in the odorant receptor OR2J3 is associated with the ability to detect the “grassy” smelling odor, cis-3-hexen-1-ol. Chem Senses 37(7):585–593PubMedCentralPubMedCrossRefGoogle Scholar
  63. Minihane AM, Jofre-Monseny L et al (2007) ApoE genotype, cardiovascular risk and responsiveness to dietary fat manipulation. Proc Nutr Soc 66(2):183–197PubMedCrossRefGoogle Scholar
  64. Morlighem JE, Harbers M et al (2011) DNA amplification techniques in pharmacogenomics. Pharmacogenomics 12(6):845–860PubMedCrossRefGoogle Scholar
  65. Murray JF (2012) Personalized medicine: been there, done that, always needs work! Am J Respir Crit Care Med 185(12):1251–1252PubMedCrossRefGoogle Scholar
  66. Mutch DM, Wahli W et al (2005) Nutrigenomics and nutrigenetics: the emerging faces of nutrition. FASEB J J19(12):1602–1616CrossRefGoogle Scholar
  67. Mutze U, Beblo S et al (2012) Metabolomics of dietary fatty acid restriction in patients with phenylketonuria. PLoS One 7(8):e43021PubMedCentralPubMedCrossRefGoogle Scholar
  68. Nielsen DE, El-Sohemy A (2012) A randomized trial of genetic information for personalized nutrition. Genes Nutr 7(4):559–566PubMedCentralPubMedCrossRefGoogle Scholar
  69. Oommen AM, Griffin JB et al (2005) Roles for nutrients in epigenetic events. J Nutr Biochem 16:74–77PubMedCrossRefGoogle Scholar
  70. Ovsyannikova IG, Poland GA (2011) Vaccinomics: current findings, challenges and novel approaches for vaccine development. AAPS J J13(3):438–444CrossRefGoogle Scholar
  71. Park KS, Shin HD et al (2006) Polymorphisms in the leptin receptor (LEPR)–putative association with obesity and T2DM. J Hum Genet 51(2):85–91PubMedCrossRefGoogle Scholar
  72. Peters U, Chatterjee N et al (2008) Variation in the selenoenzyme genes and risk of advanced distal colorectal adenoma. Cancer Epidemiol Biomarkers Prev 17(5):1144–1154PubMedCrossRefGoogle Scholar
  73. Peters BA, Kermani BG et al (2012) Accurate whole-genome sequencing and haplotyping from 10 to 20 human cells. Nature 487(7406):190–195PubMedCentralPubMedCrossRefGoogle Scholar
  74. Pickell L, Brown K et al (2011) High intake of folic acid disrupts embryonic development in mice. Birth Defects Res A Clin Mol Teratol 91(1):8–19PubMedCrossRefGoogle Scholar
  75. Roberts NJ, Vogelstein JT et al (2012) The predictive capacity of personal genome sequencing. Sci Transl Med 4(133):133ra158Google Scholar
  76. Rodriguez-Fragoso L, Martinez-Arismendi JL et al (2011) Potential risks resulting from fruit/vegetable-drug interactions: effects on drug-metabolizing enzymes and drug transporters. J Food Sci 76(4):R112–R124PubMedCrossRefGoogle Scholar
  77. Rubio-Aliaga I, Kochhar S et al (2012) Biomarkers of nutrient bioactivity and efficacy: a route toward personalized nutrition. J Clin Gastroenterol 46(7):545–554PubMedCrossRefGoogle Scholar
  78. Ruggiero A, Cefalo MG et al (2012) The role of diet on the clinical pharmacology of oral antineoplastic agents. Eur J Clin Pharmacol 68(2):115–122PubMedCrossRefGoogle Scholar
  79. Sartorius T, Staiger H et al (2012) Association of common genetic variants in the MAP4K4 locus with prediabetic traits in humans. PLoS One 7(10):e47647PubMedCentralPubMedCrossRefGoogle Scholar
  80. Shakur YA, Rogenstein C et al (2009) How much folate is in Canadian fortified products 10 years after mandated fortification? Can J Public Health 100(4):281–284PubMedGoogle Scholar
  81. Simopoulos AP (2010) Nutrigenetics/nutrigenomics. Annu Rev Public Health 31:53–68PubMedCrossRefGoogle Scholar
  82. Singh R, Kaur G et al (2011) A case of classical galactosemia: identification and characterization of 3 distinct mutations in galactose-1-phosphate uridyl transferase (GALT) gene in a single family. Indian J Pediatr 78(7):874–876PubMedCrossRefGoogle Scholar
  83. Smeets SJ, Harjes U et al (2011) To DNA or not to DNA? That is the question, when it comes to molecular subtyping for the clinic! Clin Cancer Res 17(15):4959–4964PubMedCrossRefGoogle Scholar
  84. Stover PJ, Garza C (2006) Nutrition and developmental biology – implications for public health. Nutr Rev 64(5 Pt 2):S60–S71; discussion S72–S91PubMedCrossRefGoogle Scholar
  85. Sutherland A, Kim DH et al (2010) Polymorphisms in the selenoprotein S and 15-kDa selenoprotein genes are associated with altered susceptibility to colorectal cancer. Genes Nutr 5(3):215–223PubMedCentralPubMedCrossRefGoogle Scholar
  86. Swanson JM, Entringer S et al (2009) Developmental origins of health and disease: environmental exposures. Semin Reprod Med 27(5):391–402PubMedCentralPubMedCrossRefGoogle Scholar
  87. Touhara K (2002) Odor discrimination by G protein-coupled olfactory receptors. Microsc Res Tech 58(3):135–141PubMedCrossRefGoogle Scholar
  88. Tyfield L, Reichardt J et al (1999) Classical galactosemia and mutations at the galactose-1-phosphate uridyl transferase (GALT) gene. Hum Mutat 13(6):417–430PubMedCrossRefGoogle Scholar
  89. Vakili S, Caudill MA (2007) Personalized nutrition: nutritional genomics as a potential tool for targeted medical nutrition therapy. Nutr Rev 65(7):301–315PubMedCrossRefGoogle Scholar
  90. Verschuren JJ, Trompet S et al (2012) A systematic review on pharmacogenetics in cardiovascular disease: is it ready for clinical application? Eur Heart J J33(2):165–175CrossRefGoogle Scholar
  91. Voora D, Ginsburg GS (2012) Clinical application of cardiovascular pharmacogenetics. J Am Coll Cardiol 60(1):9–20PubMedCrossRefGoogle Scholar
  92. Wadhwa PD, Buss C et al (2009) Developmental origins of health and disease: brief history of the approach and current focus on epigenetic mechanisms. Semin Reprod Med 27(5):358–368PubMedCentralPubMedCrossRefGoogle Scholar
  93. Waterland RA, Dolinoy DC et al (2006) Maternal methyl supplements increase offspring DNA methylation at axin fused. Genesis 44(9):401–406PubMedCrossRefGoogle Scholar
  94. Wu XQ, Zhu DL et al (2012) The relationship between carboxylesterase 1 gene polymorphisms and susceptibility to antituberculosis drug-induced hepatotoxicity. Zhonghua Nei Ke Za Zhi 51(7):524–530PubMedGoogle Scholar
  95. Wysocki CJ, Beauchamp GK (1984) Ability to smell androstenone is genetically determined. Proc Natl Acad Sci USA A81(15):4899–4902CrossRefGoogle Scholar
  96. Yasuji T, Kondo H et al (2012) The effect of food on the oral bioavailability of drugs: a review of current developments and pharmaceutical technologies for pharmacokinetic control. Ther Deliv 3(1):81–90PubMedCrossRefGoogle Scholar
  97. Ye K, Gu Z (2011) Recent advances in understanding the role of nutrition in human genome evolution. Adv Nutr 2(6):486–496PubMedCentralPubMedCrossRefGoogle Scholar
  98. Zempleni J, Hassan YI et al (2008) Biotin and biotinidase deficiency. Expert Rev Endocrinol Metab 3(6):715–724PubMedCentralPubMedCrossRefGoogle Scholar

Copyright information

© Springer India 2013

Authors and Affiliations

  1. 1.Division of Cancer Biology and GeneticsQueen’s University Cancer Research InstituteKingstonCanada

Personalised recommendations